Clinical trial
Screening for High Frequency Malignant Disease
NCT05117840 is registered in ClinicalTrials.gov with Guardant Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for High Frequency Malignant Disease
- Lead sponsor
- Guardant Health, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 13, 2022
- Completion date
- December 31, 2026
- Enrollment
- 12,000 (estimated)
- Sites
- 143
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer